Doug Kerr is Chief Medical Officer of Dyne Therapeutics. He completed his neurology residency and was an Associate Professor at the Johns Hopkins School of Medicine with appointments in neurology as well as molecular microbiology and immunology.

During his tenure at Johns Hopkins, he not only saw patients with motor neuron, spinal cord and neurodegenerative disorders, but he also ran a laboratory that investigated fundamental aspects of motor neuron/axon biology and neurodegeneration. Over the course of his career, Doug has served as a trusted advisor to several biotechnology and non-profit organizations through his participation in various board of director and scientific advisory positions.

He received his M.D. from Jefferson Medical College, as well as his Ph.D. in biochemistry and molecular biology from Thomas Jefferson University. He obtained his MBA, with a specialization in entrepreneurship and finance from North-eastern University and holds a B.A. in biochemistry from Princeton University.